Evidence map›Paper›PMID 16333983›Full record

ArticleCell stress & chaperones2005

Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin.

Charles E Patterson, William R Abrams, Nikolaus E Wolter, Joel Rosenbloom, Elaine C Davis

Open access · greenAbstract read
In one paragraph

Article in Cell stress & chaperones, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2015
    Article
  6. Article
  7. Connective tissue alterations in Fkbp10-/- mice.Human molecular genetics · 2014
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2011
    Article
  13. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2011
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Charles E PattersonDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas 75390-9039, USA.
William R Abrams
Nikolaus E Wolter
Joel Rosenbloom
Elaine C Davis
McGill University · CAUniversity of Pennsylvania · USThe University of Texas Southwestern Medical Center · US

Funding

TIE 1 &oxygen sensitive pulmonary vascular developmentP50HL056401 · NHLBI · CHILDRENS HOSPITAL OF PHILADELPHIA · PI BALLARD, PHILIP L. · 1996 to 2005
$11.0M
INTRACELLULAR TRAFFICKING OF TROPOELASTINR01HL060394 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI GRINNELL, FREDERICK · 1999 to 2002
$635k
NHLBI NIH HHS HL56401NHLBI NIH HHS HL60394NHLBI NIH HHS P50 HL056401
6 · The paper itself

Abstract

AFKBP65 (65-kDa FK506-binding protein) is an endoplasmic reticulum (ER)-localized peptidyl-prolyl cis-trans isomerase predicted to play a role in the folding and trafficking of secretory proteins. In previous studies, we have shown that FKBP65 is developmentally regulated and associates with the extracellular matrix protein, tropoelastin, during its maturation and transport through the ER. In this study, we show that FKBP65 is expressed in the lung with the same developmental pattern as tropoelastin and other matrix proteins. To test the hypothesis that FKBP65 is upregulated at times when extracellular matrix proteins are being actively synthesized and assembled, adult mice were treated with bleomycin to cause reinitiation of matrix protein production during the ensuing development of pulmonary fibrosis. After bleomycin instillation, FKBP65 expression was reactivated in the lung with a pattern similar to that observed for tropoelastin and type I collagen. Using human lung fibroblast cultures, we showed that FKBP65 does not undergo the unfolded protein response, a response associated with an upregulation of resident ER proteins that occurs after increased ER stress. When fibroblasts were treated with transforming growth factor (TGF)-beta1, which is upregulated during the development of pulmonary fibrosis and known to induce matrix production, FKBP65 expression and synthesis was also increased. Similar to type I collagen and tropoelastin, this response was completely inhibited in a dose-dependent manner by GGTI-298, a geranylgeranyl transferase I inhibitor. Treatment of fibroblasts with an inhibitor of ribonucleic acid (RNA) polymerase II after TGF-beta1 treatment showed that the effect of TGF-beta1 was not because of increased stabilization of the FKBP65 messenger RNA. In summary, we have shown that FKBP65 is highly expressed in lung development, downregulated in the adult, and can be reactivated in a coordinated manner with extracellular matrix proteins after lung injury. The expression pattern of FKBP65, which is atypical for general ER foldases, suggests that FKBP65 has a distinct set of developmentally regulated protein ligands. The response to injury, which may be in part a direct response to TGF-beta1, assures the presence of FKBP65 in the ER of cells actively producing components of the extracellular matrix.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsAntibiotics, AntineoplasticBleomycinCells, CulturedEndoplasmic ReticulumExtracellular Matrix ProteinsFibroblastsFibrosisHumansImmunophilinsLungMiceMice, Inbred C57BLPeptidylprolyl IsomeraseRNA StabilityAntibiotics, AntineoplasticBleomycinExtracellular Matrix ProteinsFkbp10 protein, mouseImmunophilinsPeptidylprolyl IsomeraseTacrolimus Binding ProteinsTGFB1 protein, humanTgfb1 protein, mouseTransforming Growth Factor betaTransforming Growth Factor beta1

Identifiers

PMID16333983
PMCPMC1283874
OpenAlexW2186573764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.